Kamp YJMOD, Ligt M, Dautzenberg B, Kornips E, et al. Erratum. Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial. Diabetes Care 2021;44:1334-1343. Diabetes Care 2022 Mar 3. pii: 144630. doi: 10.2337.
PMID: 35239964